miRNA Profiling of Naïve, Effector and Memory CD8 T Cells

microRNAs have recently emerged as master regulators of gene expression during development and cell differentiation. Although profound changes in gene expression also occur during antigen-induced T cell differentiation, the role of miRNAs in the process is not known. We compared the miRNA expression profiles between antigen-specific naïve, effector and memory CD8+ T cells using 3 different methods-small RNA cloning, miRNA microarray analysis and real-time PCR. Although many miRNAs were expressed in all the T cell subsets, the frequency of 7 miRNAs (miR-16, miR-21, miR-142-3p, miR-142-5p, miR-150, miR-15b and let-7f) alone accounted for ∼60% of all miRNAs, and their expression was several fold higher than the other expressed miRNAs. Global downregulation of miRNAs (including 6/7 dominantly expressed miRNAs) was observed in effector T cells compared to naïve cells and the miRNA expression levels tended to come back up in memory T cells. However, a few miRNAs, notably miR-21 were higher in effector and memory T cells compared to naïve T cells. These results suggest that concomitant with profound changes in gene expression, miRNA profile also changes dynamically during T cell differentiation. Sequence analysis of the cloned mature miRNAs revealed an extensive degree of end polymorphism. While 3′end polymorphisms dominated, heterogeneity at both ends, resembling drosha/dicer processing shift was also seen in miR-142, suggesting a possible novel mechanism to generate new miRNA and/or to diversify miRNA target selection. Overall, our results suggest that dynamic changes in the expression of miRNAs may be important for the regulation of gene expression during antigen-induced T cell differentiation. Our study also suggests possible novel mechanisms for miRNA biogenesis and function

Farmer-led innovations: Best practices and lessons learnt in livestock rearing

The livestock sector contributes 4.11% in overall GDP, however, its full potential has not been utilized, necessitating need of innovations and the use of best practices for sustainable and profitable production. Farmers are a rich source of indigenous knowledge and they innovate, experiment and adapt continuously. Documentation of these success stories may serve as a lightening conductor for other farmers. The study was carried out with 35 progressive farmers from 10 agro-climatic regions of Karnataka. The study found that stall feeding for sheep, silage preparation and storage in bunkers, low cost dairy shed and locally made milking machine were innovations made by farmers. New technology adopted by the farmers included improved crossbreeds of sheep, emu farming, high tech dairy unit and fast growing breeds of pig. Farmers frequently used literature and KVK personnel as a source of information. Development of marketing linkages, direct marketing and contract farming were important aspects in post production operations. Farmers used some of the best practices like integrated farming system; clean and hygienic methods of milking, regular vaccinations, daily chart of feed, silage and bunker storage, rotation period, use of high jet water spray for washing of animal etc. Study concluded that qualities and traits like ability to select and integrate enterprise wisely; knowing and judging market demand correctly; developing market linkages; constant seeking of information and practical intelligence to use locally available resources were the key to success of dairy farmers. Dairy extension should play a pivotal role in imparting training to farmers about these aspects and spreading the success of these innovative farmers through literature in other parts of the country for its replication on large scale

Green Synthesis of Gold Nanoparticles Mediated by Garcinia Fruits andTheir Biological Applications

Background: Green synthesis of gold nanoparticles (AuNPs) using medicinal plant extract is an emerging area of research due to their applicability in nanomedicines. Methods: In this study, aqueous extracts prepared from fruit-pericarps of two Garcinia species, G. indica (GI) and G. cambogia (GC) fruits which are important medicinally and commercially have been utilized for the synthesis of AuNPs. Various analytical techniques were utilized to characterize the synthesized AuNPs. The synthesized AuNPs were investigated for their biological properties such as antioxidant activity using the (2,2-diphenyl-1-picrylhydrazyl) DPPH model, cytotoxicity against MCF-7 (breast) cancer cell line, and antibacterial activity against two bacterial strains viz. B. subtilis and E. coli. Results: The absorption peak of the AuNPs is observed at 541 nm using UV–Visible spectroscopy. The high resolution – scanning electron microscopy images showed spherical with a triangular shape AuNPs and their average sizes were ranging from 2 – 10 nm and it was found to be in good agreement with the particle size of 8 – 11 nm determined using X-ray diffraction analysis. Fourier-transform infrared spectroscopy revealed that water-soluble biomolecules from the aqueous extracts of the Garcinia species played a crucial role in the formation of AuNPs. The synthesized AuNPs exhibited considerable cytotoxicity with IC50 values 34.55 µg/ml (GI) and 35.69 µg/ml (GC) against the MCF-7 cancer cell line. Furthermore, synthesized AuNPs also demonstrated significant antioxidant and antibacterial properties comparable to the standards used. Conclusion: AuNPs have been synthesized using a simple green approach. The synthesized AuNPs demonstrated promising cytotoxicity, antioxidant, and antibacterial properties

4-Dimensional printing: exploring current and future capabilities in biomedical and healthcare systems—a Concise review

4-Dimensional Printing (4DP) is the latest concept in the pharmacy and biomedical segment with enormous potential in dosage from personalization and medication designing, which adopts time as the fourth dimension, giving printed structures the flexibility to modify their morphology. It can be defined as the fabrication in morphology with the help of smart/intelligent materials like polymers that permit the final object to alter its properties, shape, or function in response to external stimuli such as heat, light, pH, and moisture. The applications of 4DP in biomedicines and healthcare are explored with a focus on tissue engineering, artificial organs, drug delivery, pharmaceutical and biomedical field, etc. In the medical treatments and pharmaceutical field 4DP is paving the way with unlimited potential applications; however, its mainstream use in healthcare and medical treatments is highly dependent on future developments and thorough research findings. Therefore, previous innovations with smart materials are likely to act as precursors of 4DP in many industries. This review highlights the most recent applications of 4DP technology and smart materials in biomedical and healthcare fields which can show a better perspective of 4DP applications in the future. However, in view of the existing limitations, major challenges of this technology must be addressed along with some suggestions for future research. We believe that the application of proper regulatory constraints with 4DP technology would pave the way for the next technological revolution in the biomedical and healthcare sectors

Silencing Early Viral Replication in Macrophages and Dendritic Cells Effectively Suppresses Flavivirus Encephalitis

West Nile (WN) and St. Louis encephalitis (SLE) viruses can cause fatal neurological infection and currently there is neither a specific treatment nor an approved vaccine for these infections. In our earlier studies, we have reported that siRNAs can be developed as broad-spectrum antivirals for the treatment of infection caused by related viruses and that a small peptide called RVG-9R can deliver siRNA to neuronal cells as well as macrophages. To increase the repertoire of broad-spectrum antiflaviviral siRNAs, we screened 25 siRNAs targeting conserved regions in the viral genome. Five siRNAs were found to inhibit both WNV and SLE replication in vitro reflecting broad-spectrum antiviral activity and one of these was also validated in vivo. In addition, we also show that RVG-9R delivers siRNA to macrophages and dendritic cells, resulting in effective suppression of virus replication. Mice were challenged intraperitoneally (i.p.) with West Nile virus (WNV) and treated i.v. with siRNA/peptide complex. The peritoneal macrophages isolated on day 3 post infection were isolated and transferred to new hosts. Mice receiving macrophages from the anti-viral siRNA treated mice failed to develop any disease while the control mice transferred with irrelevant siRNA treated mice all died of encephalitis. These studies suggest that early suppression of viral replication in macrophages and dendritic cells by RVG-9R-mediated siRNA delivery is key to preventing the development of a fatal neurological disease

NFAT5 Regulates HIV-1 in Primary Monocytes via a Highly Conserved Long Terminal Repeat Site

To replicate, HIV-1 capitalizes on endogenous cellular activation pathways resulting in recruitment of key host transcription factors to its viral enhancer. RNA interference has been a powerful tool for blocking key checkpoints in HIV-1 entry into cells. Here we apply RNA interference to HIV-1 transcription in primary macrophages, a major reservoir of the virus, and specifically target the transcription factor NFAT5 (nuclear factor of activated T cells 5), which is the most evolutionarily divergent NFAT protein. By molecularly cloning and sequencing isolates from multiple viral subtypes, and performing DNase I footprinting, electrophoretic mobility shift, and promoter mutagenesis transfection assays, we demonstrate that NFAT5 functionally interacts with a specific enhancer binding site conserved in HIV-1, HIV-2, and multiple simian immunodeficiency viruses. Using small interfering RNA to ablate expression of endogenous NFAT5 protein, we show that the replication of three major HIV-1 viral subtypes (B, C, and E) is dependent upon NFAT5 in human primary differentiated macrophages. Our results define a novel host factor–viral enhancer interaction that reveals a new regulatory role for NFAT5 and defines a functional DNA motif conserved across HIV-1 subtypes and representative simian immunodeficiency viruses. Inhibition of the NFAT5–LTR interaction may thus present a novel therapeutic target to suppress HIV-1 replication and progression of AIDS

Rationale and protocol for estimating the economic value of a multicomponent quality improvement strategy for diabetes care in South Asia.

BACKGROUND: Economic dimensions of implementing quality improvement for diabetes care are understudied worldwide. We describe the economic evaluation protocol within a randomised controlled trial that tested a multi-component quality improvement (QI) strategy for individuals with poorly-controlled type 2 diabetes in South Asia. METHODS/DESIGN: This economic evaluation of the Centre for Cardiometabolic Risk Reduction in South Asia (CARRS) randomised trial involved 1146 people with poorly-controlled type 2 diabetes receiving care at 10 diverse diabetes clinics across India and Pakistan. The economic evaluation comprises both a within-trial cost-effectiveness analysis (mean 2.5 years follow up) and a microsimulation model-based cost-utility analysis (life-time horizon). Effectiveness measures include multiple risk factor control (achieving HbA1c < 7% and blood pressure < 130/80 mmHg and/or LDL-cholesterol< 100 mg/dl), and patient reported outcomes including quality adjusted life years (QALYs) measured by EQ-5D-3 L, hospitalizations, and diabetes related complications at the trial end. Cost measures include direct medical and non-medical costs relevant to outpatient care (consultation fee, medicines, laboratory tests, supplies, food, and escort/accompanying person costs, transport) and inpatient care (hospitalization, transport, and accompanying person costs) of the intervention compared to usual diabetes care. Patient, healthcare system, and societal perspectives will be applied for costing. Both cost and health effects will be discounted at 3% per year for within trial cost-effectiveness analysis over 2.5 years and decision modelling analysis over a lifetime horizon. Outcomes will be reported as the incremental cost-effectiveness ratios (ICER) to achieve multiple risk factor control, avoid diabetes-related complications, or QALYs gained against varying levels of willingness to pay threshold values. Sensitivity analyses will be performed to assess uncertainties around ICER estimates by varying costs (95% CIs) across public vs. private settings and using conservative estimates of effect size (95% CIs) for multiple risk factor control. Costs will be reported in US$ 2018. DISCUSSION: We hypothesize that the additional upfront costs of delivering the intervention will be counterbalanced by improvements in clinical outcomes and patient-reported outcomes, thereby rendering this multi-component QI intervention cost-effective in resource constrained South Asian settings. TRIAL REGISTRATION: ClinicalTrials.gov: NCT01212328

Improved siRNA/shRNA Functionality by Mismatched Duplex

siRNA (small interfering RNA) and shRNA (small hairpin RNA) are powerful and commonly used tools in biomedical research. Currently, siRNAs are generally designed as two 21 nt strands of RNA that include a 19 nt completely complementary part and a 2 nt overhang. However, since the si/shRNAs use the endogenous miRNA machinery for gene silencing and the miRNAs are generally 22 nt in length and contain multiple internal mismatches, we tested if the functionality can be increased by designing the si/shRNAs to mimic a miRNA structure. We systematically investigated the effect of single or multiple mismatches introduced in the passenger strand at different positions on siRNA functionality. Mismatches at certain positions could significantly increase the functionality of siRNAs and also, in some cases decreased the unwanted passenger strand functionality. The same strategy could also be used to design shRNAs. Finally, we showed that both si and miRNA structured oligos (siRNA with or without mismatches in the passenger strand) can repress targets in all individual Ago containing cells, suggesting that the Ago proteins do not differentiate between si/miRNA-based structure for silencing activity

चितलवाना पंचायत समिति में मानव गरीबी सूचकांक - 2016 ( à¤à¤• गà¥à¤°à¤¾à¤® सà¥à¤¤à¤°à¥€à¤¯ भौगोलिक अधà¥à¤¯à¤¯à¤¨ )

राजसà¥à¤¥à¤¾à¤¨ के पशà¥à¤šà¤¿à¤®à¥€ भाग में सà¥à¤¥à¤¿à¤¤ मरूसà¥à¤¥à¤²à¥€à¤¯ जिले सामाजिक-आरà¥à¤¥à¤¿à¤• विकास की दृषà¥à¤Ÿà¤¿ से पिछड़े हà¥à¤ हैं। अतः इन जिलों में रहने वाले लोगों में गरीबी का सà¥à¤¤à¤° उचà¥à¤š पाया जाता है। विशेष रूप से गà¥à¤°à¤¾à¤®à¥€à¤£ कà¥à¤·à¥‡à¤¤à¥à¤°à¥‹à¤‚ में जहां कृषि, उदà¥à¤¯à¥‹à¤— à¤à¤µà¤‚ रोजगार के अवसरों की कमी के कारण इन कà¥à¤·à¥‡à¤¤à¥à¤°à¥‹à¤‚ में गरीबी की पà¥à¤°à¤µà¥ƒà¤¤à¥à¤¤à¤¿ कई गà¥à¤¨à¤¾ बढ़ जाती हैं। आज भी देश कà¥à¤› गà¥à¤°à¤¾à¤®à¥€à¤£ हिसà¥à¤¸à¥‹à¤‚ को छोड़कर अधिकांश हिसà¥à¤¸à¥‹à¤‚ में गà¥à¤°à¤¾à¤®à¥€à¤£ आबादी गरीबी, भूखमरी, बेरोजगारी, अशिकà¥à¤·à¤¾, कà¥à¤ªà¥‹à¤·à¤£, भà¥à¤°à¤·à¥à¤Ÿà¤¾à¤šà¤¾à¤°, सामनà¥à¤¤à¤µà¤¾à¤¦, सà¥à¤µà¤¾à¤¸à¥à¤¥à¥à¤¯ सà¥à¤µà¤¿à¤§à¤¾à¤“ं में कमी जैसी कई समसà¥à¤¯à¤¾à¤“ं से जूठरही हैं।  इन गà¥à¤°à¤¾à¤®à¥€à¤£ कà¥à¤·à¥‡à¤¤à¥à¤°à¥‹à¤‚ में कृषि, पशà¥à¤ªà¤¾à¤²à¤¨, उदà¥à¤¯à¥‹à¤—, à¤à¤µà¤‚ रोजगार के अवसर, बेहतर शिकà¥à¤·à¤¾-सà¥à¤µà¤¾à¤¸à¥à¤¥à¥à¤¯ सà¥à¤µà¤¿à¤§à¤¾, संचार à¤à¤µà¤‚ परिवहन के साधनों  के अभाव के कारण गरीबी का सà¥à¤¤à¤° सरà¥à¤µà¥‹à¤šà¥à¤š हैं। कà¥à¤·à¥‡à¤¤à¥à¤° में मानव गरीबी सूचकांक के सà¥à¤¤à¤° का आंकलन करने पर जà¥à¤žà¤¾à¤¤ होता है कि चितलवाना पंचायत समिति की सà¥à¤°à¤¾à¤šà¤‚द (0.856) गà¥à¤°à¤¾à¤® पंचायत में मानव गरीबी सूचकांक उचà¥à¤š, जबकि डी. à¤à¤¸. ढाणी (0.279) गà¥à¤°à¤¾à¤® पंचायत में सबसे निमà¥à¤¨ पाया जाता हैंà¥